186 related articles for article (PubMed ID: 36685860)
1. Identification of oncogenes and tumor-suppressor genes with hepatocellular carcinoma: A comprehensive analysis based on TCGA and GEO datasets.
Zhu Y; Wang Y; Hu M; Lu X; Sun G
Front Genet; 2022; 13():934883. PubMed ID: 36685860
[No Abstract] [Full Text] [Related]
2. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
3. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
4. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
PeerJ; 2021; 9():e11342. PubMed ID: 33987018
[TBL] [Abstract][Full Text] [Related]
5. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma.
Wang J; Wang Y; Xu J; Song Q; Shangguan J; Xue M; Wang H; Gan J; Gao W
Sci Prog; 2021; 104(3):368504211029429. PubMed ID: 34315286
[TBL] [Abstract][Full Text] [Related]
6. Identification and validation of real hub genes in hepatocellular carcinoma based on weighted gene co-expression network analysis.
Qiao Y; Yuan F; Wang X; Hu J; Mao Y; Zhao Z
Cancer Biomark; 2022; 35(2):227-243. PubMed ID: 36120772
[TBL] [Abstract][Full Text] [Related]
7. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
Yang SY; Ren H; Li CF; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
[No Abstract] [Full Text] [Related]
8. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
9. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
10. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
[TBL] [Abstract][Full Text] [Related]
11. Identifying potential prognosis markers in hepatocellular carcinoma
Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
Front Genet; 2022; 13():942454. PubMed ID: 35928445
[No Abstract] [Full Text] [Related]
12. Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma.
Cai D; Zhao Z; Hu J; Dai X; Zhong G; Gong J; Qi F
Front Surg; 2022; 9():836080. PubMed ID: 35392063
[TBL] [Abstract][Full Text] [Related]
13. RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma.
Rao B; Li J; Ren T; Yang J; Zhang G; Liu L; Wang H; Huang M; Ren Z; Yu Z
Front Cell Dev Biol; 2021; 9():686547. PubMed ID: 34350180
[TBL] [Abstract][Full Text] [Related]
14. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
Yu Y; Cheng J; Mei CZ; Dai YZ
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
[TBL] [Abstract][Full Text] [Related]
15. Identification of a five-gene signature in association with overall survival for hepatocellular carcinoma.
Yang L; Yin W; Liu X; Li F; Ma L; Wang D; Li H
PeerJ; 2021; 9():e11273. PubMed ID: 33986994
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Epigenetic Associated Genes on Differential Gene Expression and Prognosis in Hepatocellular Carcinoma.
Li C; Ding J; Mei J
J Environ Pathol Toxicol Oncol; 2022; 41(1):27-43. PubMed ID: 35378002
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma.
Sha M; Cao J; Zong ZP; Xu N; Zhang JJ; Tong Y; Xia Q
Ann Transl Med; 2021 Jun; 9(12):975. PubMed ID: 34277775
[TBL] [Abstract][Full Text] [Related]
18. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
[TBL] [Abstract][Full Text] [Related]
19. C18ORF54 promotes immune infiltration and poor prognosis as a potential biomarker for hepatocellular carcinoma.
Ma Y; Yan D; Tian F; Song W; Sha R; Shang X; Lv J; Maimaiti N; Kong P; Ma X
Am J Transl Res; 2023; 15(8):5007-5034. PubMed ID: 37692934
[TBL] [Abstract][Full Text] [Related]
20. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol‑associated hepatocellular carcinoma using weighted gene co‑expression network analysis.
Bi N; Sun Y; Lei S; Zeng Z; Zhang Y; Sun C; Yu C
Oncol Rep; 2020 Aug; 44(2):611-627. PubMed ID: 32627011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
